Behavioural supersensitivity may be caused by increased glutamate sensitivity and reduced dopamine sensitivity of D2-MSN. We propose that clozapine may address this issue by modulating glutamate activity, which may explain its unique effectiveness in treating treatment resistant schizophrenia.
Behavioural supersensitivity may be a result of increased glutamate sensitivity of D2-MSN and reduced sensitivity to dopamine. We propose that clozapine may address behavioural supersensitivity by modulating glutamate activity which may partially explain its unique effectiveness in the setting of treatment resistant schizophrenia.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据
分享论文
